Methods of treating disseminated intravascular coagulation using anti-TNF antibodies
US7135178B2 · kind B2 · utility
15Cited by
23References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 20, 2002 |
| Grant date | Nov 14, 2006 |
| Priority date | — |
| Expiry date | Aug 7, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful for therapy of TNFα-mediated pathologies and conditions, including vascular inflammatory pathologies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.